|
GraphPad Software Inc
survival calculation tool graphpad prism Survival Calculation Tool Graphpad Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/graphpad+calculator/graphpad+prism+tool/pmc08033524__EMMM___13___e13162___s001-538-10-10 Average 90 stars, based on 1 article reviews
survival calculation tool graphpad prism - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GraphPad Software Inc
statistical calculations graphpad prism 8 Statistical Calculations Graphpad Prism 8, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/graphpad+calculator/graphpad+prism+8/pmc10962953__pnas__2318176121__sapp-139-9-9 Average 90 stars, based on 1 article reviews
statistical calculations graphpad prism 8 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GraphPad Software Inc
area under the curve (auc) calculated by graphpad prism Area Under The Curve (Auc) Calculated By Graphpad Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/graphpad+calculator/area+under+the+curve++auc++calculated+by+graphpad+prism/pm40650904-107-20-20 Average 90 stars, based on 1 article reviews
area under the curve (auc) calculated by graphpad prism - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GraphPad Software Inc
graphpad chi-square calculator Graphpad Chi Square Calculator, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/graphpad+calculator/chi+square+calculator/pmc12264594-251-6-10 Average 90 stars, based on 1 article reviews
graphpad chi-square calculator - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GraphPad Software Inc
graphpad outlier calculator Graphpad Outlier Calculator, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/graphpad+calculator/quickcalcs/pm40441390-177-8-11 Average 90 stars, based on 1 article reviews
graphpad outlier calculator - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GraphPad Software Inc
online t-test calculator graphpad prizm Online T Test Calculator Graphpad Prizm, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/graphpad+calculator/online+t+test+calculator+graphpad+prizm/10__1016_slash_j__rechem__2025__102385-139-5-5 Average 90 stars, based on 1 article reviews
online t-test calculator graphpad prizm - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GraphPad Software Inc
roc curve calculated using graphpad prism software Roc Curve Calculated Using Graphpad Prism Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/graphpad+calculator/graphpad+prism+software/pm40394099-128-20-28 Average 90 stars, based on 1 article reviews
roc curve calculated using graphpad prism software - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GraphPad Software Inc
pearson’s correlation coefficient(r) calculated in graphpad prism ![]() Pearson’s Correlation Coefficient(r) Calculated In Graphpad Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/graphpad+calculator/correlation+coefficient/pmc12064836-34-6-11 Average 90 stars, based on 1 article reviews
pearson’s correlation coefficient(r) calculated in graphpad prism - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GraphPad Software Inc
online calculator graphpad ![]() Online Calculator Graphpad, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/graphpad+calculator/online+graphpad+calculator/pmc12145132-43-7-8 Average 90 stars, based on 1 article reviews
online calculator graphpad - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Journal: Nature Communications
Article Title: Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer
doi: 10.1038/s41467-025-59588-3
Figure Lengend Snippet: a , b Scatterplot showing the relationship between gene-level alteration frequencies in ctDNA and archival tissues from ( a ) 141 patients who received prior anti-VEGF therapies, and ( b )113 patients who received prior anti-EGFR therapies. The effect size was estimated using Pearson’s correlation coefficient(r) calculated in GraphPad Prism, and the coefficient of determination (r 2 ), representing the proportion of variance explained by the relationship, is displayed on the scatter plot. c Comparison of percentage of patients with emerging alterations between patients with prior anti-EGFR therapies and those with prior anti-VEGF therapies. Alterations that were absent from tumor tissue samples but detected in plasma samples were defined as emerging alterations. (All genes with at least one emerging alteration listed). Only known and likely oncogenic alterations in each gene were considered for the analysis. P- value was calculated using a two-tailed Fisher’s exact test to compare the percentage of patients with emerging alterations between those who received anti-EGFR therapies and those who received anti-VEGF therapies. Source data are provided as a Source Data file.
Article Snippet: The effect size was estimated using
Techniques: Comparison, Clinical Proteomics, Two Tailed Test